Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -51.361% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1c(C(c2cccc([N+](=O)[O-])c2O)c2c(C)n(C)n(-c3ccccc3)c2=O)c(=O)n(-c2ccccc2)n1C
b OC1(c2ccc3c(c2)OCO3)CCN(Cc2ccc(F)cc2)CC1
Answer: b. OC1(c2ccc3c(c2)OCO3)CCN(Cc2ccc(F)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
OC1(c2ccc3c(c2)OCO3)CCN(Cc2ccc(F)cc2)CC1
OC1(c2ccc3c(c2)OCO3)CCN(Cc2ccc(F)cc2)CC1
4-(1,3-benzodioxol-5-yl)-1-[(4-fluorophenyl)methyl]piperidin-4-ol